Compare ACLX & AVPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACLX | AVPT |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | United States | United States |
| Employees | N/A | 2934 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 2.3B |
| IPO Year | 2022 | N/A |
| Metric | ACLX | AVPT |
|---|---|---|
| Price | $114.53 | $10.46 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 11 |
| Target Price | ★ $115.85 | $16.64 |
| AVG Volume (30 Days) | ★ 3.4M | 1.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $22,286,000.00 | N/A |
| Revenue This Year | $329.40 | $22.66 |
| Revenue Next Year | $151.37 | $19.11 |
| P/E Ratio | ★ N/A | $1,348.94 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $47.86 | $9.86 |
| 52 Week High | $114.80 | $20.25 |
| Indicator | ACLX | AVPT |
|---|---|---|
| Relative Strength Index (RSI) | 83.40 | 41.96 |
| Support Level | $66.06 | $9.86 |
| Resistance Level | $114.80 | $11.42 |
| Average True Range (ATR) | 0.34 | 0.38 |
| MACD | -0.89 | 0.04 |
| Stochastic Oscillator | 75.89 | 24.40 |
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.